ArticleScientific reports2026
Comparative study on changes in serum amino acid metabolic profiles in mice exposed to perfluorooctanoic acid and sodium ρ-perfluorous nonenoxybenzene sulfonate.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Perfluorinated compounds (PFCs) such as perfluorooctanoic acid (PFOA) and sodium ρ-perfluorous nonenoxybenzene sulfonate (OBS) are toxic to organisms, but their toxicological differences in affecting serum amino acid metabolism remain unclear. To investigate the effects of subchronic PFOA and OBS exposure on mice’s serum amino acid metabolic profile and explore their toxicological differences. Fifteen healthy male C57BL/6N mice were randomly divided into three groups: control (CON) group, PFOA group (exposed to 3 mg/(kg·d) PFOA), and OBS group (exposed to 3 mg/(kg·d) OBS). The experiment was conducted continuously for four weeks. After the exposure period, serum samples were collected, and the concentrations of free amino acids and their derivatives in the serum were determined using an automatic amino acid analyzer. Principal component analysis (PCA) and orthogonal partial least-squares discriminant analysis (OPLS-DA) were used for data analysis. PCA and OPLS-DA results showed distinct intra-group clustering and clear inter-group separation of the serum amino acid metabolic profiles. A total of 23 differential amino acids and their derivatives were identified with the criterion of variable importance in projection (VIP) > 1.0. Quantitative analysis indicated that neither PFOA nor OBS exposure significantly altered the total serum amino acid levels in mice, but both selectively disrupted the metabolic homeostasis of specific amino acids and their derivatives. For essential amino acids, exposure to either PFOA or OBS significantly increased serum leucine levels; serum threonine levels were significantly decreased in the PFOA group but increased in the OBS group. For non-essential amino acids, the levels of serine, asparagine, and glutamine in the OBS group were significantly higher than those in both the CON and PFOA groups. Regarding amino acid derivatives, 11 compounds showed highly significant differences (P < 0.01) and 3 showed significant differences (P < 0.05) among the three groups. Subchronic exposure to both PFOA and OBS significantly disrupts the serum amino acid metabolic profile in mice. However, the two compounds exhibited distinct effects: OBS exerted a broader impact on non-essential amino acids (serine, asparagine, glutamine), while PFOA showed a stronger association with cardiovascular and muscle toxicity markers (homocysteine, 1-methylhistidine). These findings suggest that PFOA and OBS may exert toxic effects through different molecular mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.